Determinants of low measles vaccination coverage in children living in an endemic area.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 19 08 2018
accepted: 05 11 2018
revised: 30 10 2018
pubmed: 16 11 2018
medline: 29 1 2019
entrez: 16 11 2018
Statut: ppublish

Résumé

Measles outbreaks were recently reported in Europe due to low immunization rates. In this scenario, identifying the reasons of no vaccination is crucial to set up strategies to improve immunization rate. A cross-sectional study was conducted to investigate the determinants of missed vaccination in children living in Southern Italy, during the 2016 outbreak. A standardized face-to-face questionnaire was used to record demographic data, immunization status, and reasons for missed vaccination. A total of 1141 children (median age 86 months, male 47.2%) was enrolled, 77.8% of the children were adequately vaccinated for age, 6.3% were incompletely vaccinated for age, and 15.9% did not receive any vaccine dose. Vaccination rate and reasons for not vaccinating significantly varied according to age, with children ≤ 24 months showing the lowest rate (67.8%). Reasons for not vaccinating included fear for side effects (51%), presence of underlying chronic conditions (12.2%), skip scheduled appointment (12.2%), refusal of vaccination (10.3%), acute illnesses (7.2%), and allergy to eggs (4.6%). The presence of underlying condition was a risk factor for inadequate immunization (p < 0.0001). Only 4.7% of conditions were true contraindications to vaccine administration.Conclusion: We reported inadequate measles immunization rate in Southern Italy, with lowest rates in children ≤ 2 years or with underlying conditions. Only a minority had true contraindications to vaccine uptake. Implementation strategies addressed to health-care professionals and families should focus on the reported determinants to increase measles vaccination coverage. What is Known: • Measles is a viral, highly communicable disease, preventable by vaccine. • Measles elimination in Europe failed as demonstrated by outbreaks in several countries, due to low immunization rates. What is New: • Inadequate measles immunization rate due to false contraindications in Southern Italy, with lowest rates in children ≤ 2 years. • The presence of underlying disease is a risk factor for inadequate immunization.

Identifiants

pubmed: 30430239
doi: 10.1007/s00431-018-3289-5
pii: 10.1007/s00431-018-3289-5
doi:

Substances chimiques

Measles Vaccine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-251

Références

MMWR Morb Mortal Wkly Rep. 2003 Oct 31;52(43):1044-7
pubmed: 14586297
J Child Psychol Psychiatry. 2005 Jun;46(6):572-9
pubmed: 15877763
Arch Pediatr Adolesc Med. 2005 Jun;159(6):596; author reply 596-7
pubmed: 15939864
Pediatrics. 2006 Jul;118(1):e139-50
pubmed: 16818529
Vaccine. 2006 Nov 30;24(49-50):7238-45
pubmed: 17052810
Vaccine. 2010 Jun 11;28(26):4235-48
pubmed: 20438879
Arch Dis Child. 2010 May;95(5):399-400
pubmed: 20457709
BMJ. 2011 Jan 05;342:c7452
pubmed: 21209060
J Infect Dis. 2011 Jul;204 Suppl 1:S335-42
pubmed: 21666182
Euro Surveill. 2013 May 16;18(20):null
pubmed: 23725868
MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1-34
pubmed: 23760231
Vaccine. 2014 Jun 5;32(27):3357-61
pubmed: 24793952
JAMA. 2015 Apr 21;313(15):1534-40
pubmed: 25898051
Am J Epidemiol. 2016 Jul 15;184(2):148-56
pubmed: 27338281
Nat Rev Dis Primers. 2016 Jul 14;2:16049
pubmed: 27411684
J Pediatr. 2016 Aug;175:248-249.e1
pubmed: 27507319
Euro Surveill. 2016 Aug 11;21(32):
pubmed: 27541858
JAMA Pediatr. 2016 Dec 1;170(12):1209-1215
pubmed: 27695849
Hum Vaccin Immunother. 2017 Jul 3;13(7):1693-1699
pubmed: 28362544
JAMA Pediatr. 2017 Sep 1;171(9):887-892
pubmed: 28738137
Expert Rev Vaccines. 2017 Nov;16(11):1107-1118
pubmed: 28914112
Vaccine. 2018 Feb 1;36(6):779-787
pubmed: 29325822
Am J Epidemiol. 1983 Jan;117(1):2-13
pubmed: 6337476

Auteurs

Andrea Lo Vecchio (A)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy. andrealovecchio@gmail.com.

Maria Donata Cambriglia (MD)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

Maria Cristina Fedele (MC)

Department of Woman, Child, and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.

Francesca Wanda Basile (FW)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

Fabrizia Chiatto (F)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

Michele Miraglia Del Giudice (M)

Department of Woman, Child, and General and Specialized Surgery, University of Campania Luigi Vanvitelli, Naples, Italy.

Alfredo Guarino (A)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Via Pansini 5, 80131, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH